CompletedPhase 1

A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema

United States27 participantsStarted 2006-07

Plain-language summary

A Phase I Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Non-childbearing potential (i.e., physiologically incapable of becoming pregnant), including any female who:
✓. Childbearing potential, has a negative serum pregnancy test at screening, and agrees to one of the following:

Toxicity (Number of Patients Who Experiened DLTs)

Timeframe: until death, approximately 2 years

NCT IDNCT00439179

SponsorBrown University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-12

Results submitted2013-05-13